Cytokinetics, Incorporated
CYTK
$74.13
$0.680.93%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 35.84% | -12.75% | -18.01% | -4.86% | -18.80% |
| Total Receivables | 190.51% | 239.31% | 6.69% | 640.98% | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | -10.04% | -11.94% | 11.22% | 95.14% | 81.21% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 36.31% | -12.19% | -17.24% | -4.05% | -16.98% |
|
|
|||||
| Total Current Assets | 36.31% | -12.19% | -17.24% | -4.05% | -16.98% |
| Net Property, Plant & Equipment | 3.74% | 8.55% | 10.07% | 9.26% | 2.38% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 43.85% | 75.72% | 125.06% | 117.61% | 89.52% |
| Total Assets | 57.02% | 0.75% | 1.63% | 0.03% | -19.57% |
|
|
|||||
| Total Accounts Payable | 26.39% | 77.23% | 9.66% | 90.69% | 71.36% |
| Total Accrued Expenses | 46.92% | 58.82% | 50.53% | 23.70% | 31.40% |
| Short-term Debt | 74.43% | 152.99% | 175.22% | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 42.42% | 102.15% | 97.69% | 24.86% | 13.18% |
| Total Finance Division Other Current Liabilities | -54.67% | -82.39% | -91.24% | -80.03% | -53.40% |
| Total Other Current Liabilities | -54.67% | -82.39% | -91.24% | -80.03% | -53.40% |
| Total Current Liabilities | 38.43% | 24.70% | 12.68% | 29.44% | 27.52% |
|
|
|||||
| Total Current Liabilities | 38.43% | 24.70% | 12.68% | 29.44% | 27.52% |
| Long-Term Debt | 46.79% | 62.58% | 61.27% | 55.26% | 31.60% |
| Short-term Debt | 74.43% | 152.99% | 175.22% | -- | -- |
| Capital Leases | -7.75% | -7.16% | -4.10% | -3.57% | -4.87% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 13.00% | 12.13% | 12.19% | 12.50% | -8.47% |
| Total Liabilities | 31.59% | 37.22% | 35.60% | 35.02% | 12.66% |
|
|
|||||
| Common Stock & APIC | 41.57% | 10.50% | 10.24% | 9.88% | 5.13% |
| Retained Earnings | -29.82% | -28.98% | -29.05% | -29.47% | -25.36% |
| Treasury Stock & Other | -2,321.52% | -204.34% | -73.73% | -99.37% | 84.54% |
| Total Common Equity | 52.95% | -210.26% | -387.27% | -3,646.12% | -439.68% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 52.95% | -210.26% | -387.27% | -3,646.12% | -439.68% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 52.95% | -210.26% | -387.27% | -3,646.12% | -439.68% |
|
|
|||||